Evaluating Machine Learning Classifiers for Predicting Liver Disease Outcomes

The increasing prevalence of liver disease necessitates the development of accurate predictive models to aid in early diagnosis and treatment. This study investigates the effectiveness of several machine learning classifiers, Random Forest, Gradient Boosting, AdaBoost, Support Vector Machine (SVM), and Logistic Regression, in predicting liver disease outcomes based on clinical and biochemical features. Each model's performance was rigorously evaluated using multiple metrics, including F1-score, accuracy, root mean square error (RMSE), mean absolute error (MAE), precision, recall, and cross-validation ROC-AUC scores. The Random Forest Classifier emerged as the most effective model, achieving a perfect accuracy of 100% and an F1-score of 1.00, suggesting its robustness in handling complex, high-dimensional data. The Gradient Boosting Classifier also demonstrated commendable performance with an accuracy of 89% and an F1-score of 0.85, indicating its efficacy in capturing the underlying patterns of liver disease. Conversely, Logistic Regression and SVM exhibited lower performance metrics, pointing to potential limitations in their ability to model the intricacies of liver disease data effectively. The insights from this study not only enhance our understanding of liver disease prediction using machine learning but also emphasize the need for further research to validate these models in diverse clinical populations. This study contributes to the growing body of literature advocating for the integration of machine learning techniques in clinical decision-making processes, ultimately aiming to improve patient outcomes in liver disease management.